Pharmacology Flashcards
What does the stimulation of postganglionic cholinergic neurones cause?
- Bronchial smooth muscle contraction (M3 receptors)
- Increased mucus secretion (M3 receptors on goblet cells)
What does the stimulation of postganglionic parasympathetic non-cholinergic neurones cause?
Stimulation of postganglionic parasympathetic neurons typically causes constriction of the airways.
This is why anticholinergic medications, which block the muscarinic receptors, are often used to treat asthma and other respiratory conditions that involve airway constriction.
In which four ways does the sympathetic system affect the airways?
- Bronchial smooth muscle
- Mucous secretion
- Mucociliary clearance
- Vascular smooth muscle contraction
Bronchial smooth muscle is not innervated by sympathetic neurones - how does the sympathetic system influence the bronchi?
There is no postganglionic neurone, so innervation of the adrenal gland allows it to act as this neurone, by releasing adrenaline which can cause bronchial smooth muscle by binding to B2 adrenoceptors
What are the receptors associated with the sympathetic system in submucosal glands and what is their activated effect?
B2 adrenoceptors (act on goblet cells and epithelium) Reduces mucus secretion and increases clearance (mucociliary elevator)
Which receptor mediated vascular smooth muscle contraction?
alpha1 adrenoceptors
What is the sarcoplasmic reticulum?
Type of endoplasmic reticulum that regulates calcium ion concentration in skeletal muscle
During motor neurone conduction in skeletal muscle, what type of receptor is activated after hormone or neurotransmitter release?
G protein coupled receptor (Gq and phospholipase)
How is IP3 produced during skeletal muscle contraction?
Produced from PIP2 (phosphatidylinositol (4,5) biphosphate after Gq subunit binds to phospholipase
What is the function of IP3 in skeletal muscle contraction?
Produced IP3 acts as a substrate for the IP3 receptor (transmembrane) which, when bound, allows efflux of calcium ions out of the sarcoplasmic reticulum and into the cytoplasm. Contraction is now viable
Describe how calcium can aid the pathway of smooth muscle contraction
When the impulse arrives, voltage gated calcium channels open calcium an influx of calcium into the cytoplasm. Calcium can then activate ryodine receptors (calcium activated channels). This allows for calcium efflux out of the sarcoplasmic reticulum
Which two main things must be available for muscle contraction to occur?
- ATP
- Calcium
Why is calcium required for muscle contraction?
Calcium combines with calmodulin which creates a complex that activates MLCK
What does activated MLCK allow for?
Activated MLCK breaks down ATP allowing inactive myosin cross-bridges to enter the cocked position and able to bind with actin filaments
What causes smooth muscle relaxation?
Dephosphorylation of myosin light chain (MLC) by MLC phosphotase
When levels of calcium are high in smooth muscle cells, the rate of phosphorylation will be much higher than dephosphorylation, so for relaxation to occur, what must happen to the levels of calcium
They must reduce
What effect does adrenaline have when binding to B2 adrenoceptors in smooth muscle?
- G protein couples receptor activated (Gs)
- Complex activates adenylyl cyclase which boots cAMP levels
- cAMP combines to PKA
- PKA facilitates smooth muscle relaxation
In what 2 ways does PKA stimulate smooth muscle relaxation?
- Phosphorylating and inhibting MLCK which inhibits contraction
- Phosphorylating and stimulating myosin phosphotase which facilitates relaxation
Chronic asthma can have many negative effects, what are some of these?
- Increase in smooth muscle reducing bronchiole diameter
- Inflammation causes build up of oedema
- Increased mucus secretion into lungs causes partial obstruction
- Epithelial lining becomes damaged and cells are shed which exposes sensory nerve endings causing irritability
- Sub-epithelial fibrosis - epithelial cells deposit excess collagen reducing space further in airways
What causes bronchial hyper-responsiveness in asthma?
Epithelial damage leads to C-fibre (irritation receptor) exposure causing increased sensitivity to bronchoconstrictor influences
As a result of epithelial damage in asthma, neurogenic inflammation occurs - what are the cosequences of this?
Various peptides are released from these nerve endings
Which two components contribute to the severity of asthma?
- Hyper-sensitivity - concentration of bronchoconstrictor influences that will evoke asthmatic response
- Hyper-reactivity - The severity of the response experienced
What composes the immediate reaction in an asthma attack?
Initial bronchospasm and acute inflammation
What composes the delayed reaction of asthma?
Continued bronchospasm and delayed inflammation.
continued bronchospasm, which is the constriction of the airways due to the contraction of smooth muscle cells in the bronchioles. This can further worsen symptoms such as wheezing, shortness of breath, and coughing.
Due to the two phases to an asthma attack, the FEV1 changes over time, but in what ways?
FEV1 - decreases after initial reaction (immediate)
FEV1 - recovers after the immediate reaction
FEV1 - deteriorates again during delayed reaction
FEV1 - recovers fully
How does atopic asthma differ from non-atopic asthma in relation to immune system activation?
Non-atopic - low-level immune response TH1 response which mediates IgG and macrophages
Atopic - strong TH2 response that is an antibody mediated immune response involving IgE
What are TH0 cells?
Precursors
They differentiate to either TH1 or TH2 cells
In the development of allergic asthma describe the induction phase
- Allergen recognition: An allergen is recognized by antigen-presenting cells (APCs), such as dendritic cells or macrophages, which phagocytose or endocytose the allergen and present it on their MHC-II molecules.
- Th2 cell activation: APCs present the allergen to Th2 cells, which recognize it through their TCR and release cytokines such as IL-4 and IL-5.
- IgE production: IL-4 induces plasma cells to produce specific IgE antibodies against the allergen.
- Mast cell activation: IgE antibodies bind to FcεR1 receptors on mast cells, leading to their degranulation and release of histamines and leukotrienes.
- Eosinophil activation: IL-5 activates eosinophils, which release leukotrienes and proteases that can cause tissue damage to the respiratory tract if released chronically.
Overall, the induction phase of allergic asthma involves the activation of various immune cells and the production of IgE antibodies that can bind to mast cells and trigger their degranulation, leading to airway inflammation and hyperresponsiveness.
In the development of allergic asthma describe the effector phase
- Plasma cells secrete IgE antibodies due to interleukin 4 action
- Interleukin 5 is released from TH2 cells which activates eosinophils
- Mast cells express IgE receptors and become activated due to release of IL-4 and IL-13
What are the two phases to the development of allergic asthma?
- Induction phase
- Effector phase
How do mast cells become activated in allergic asthma?
Antigens combine with IgE antibodies on the surface of mast cells
What happens during mast cell activation in allergic asthma?
Calcium enters via calcium channels and it is released from intracellular stores
- Mast cell secrete histamine, leukotrienes (LTC4, LTD4) - causes contraction of airways
- Mast cells release substances (chemokines/chemotaxins) that attract inflammation causing cells to the area
This explains the primary and secondary responses to an asthma attack
The repeated exposure also leads to the recruitment of more inflammatory cells, such as eosinophils, which can cause further damage to the airways.
What happens when mast cells release chemotaxins and chemokines during allergic asthma?
- TH2 cells infiltrate the area with monocytes (TH1 may also be involved)
- Inflammatory cells such as eosinophils become activated
- Eosinophils cause damage to epithelium
What are the two main types of drugs are used in asthm anad which drug classes are used for each?
Relievers - bronchodilators
- SABAs
- LABAs
- CysLT1 receptor antagonists
Controllers/preventors - anti-inflammatory
- Glucocorticoids
- Cromoglicate
- Humanised monoclonal IgE antibodies
Why are LABAs never given as monotherapy?
Monotherapy of LABAs can be harmful
Receptors can lose sensitivity and pharmacological effect over time decreases
This can cause a long-term decrease in the amount of B2 adrenoceptors as they are withdrawn from the surface of cells and potentially broken down by lysomes
During stage 3 of asthma treatment, what happens if there is no response to the added LABA?
Dose of ICS is increased
And, if required trial of other therapies such as a CysLT1 receptr antagonist or theophylline is used
What are the three classes of B2-adrenoceptor agonists?
- SABAs
- LABAs
- Ultra LABAs
Why are SABAs administered by inhalation?
This reduces the dose required and therefore the systemic effects experienced
What are some of the potential side effects to SABAs?
- Tachycardia
- Cardiac dysrhythmias
- Hypokalaemia
What 3 things do SABAs achieve?
- Bronchodilatation
- Increased mucus clearance
- Decreased mediator release of mast cells and monocytes
LABAs are always co-administered with a ______________
Glucocorticoid
What is the benefit that LABAs have over SABAs?
They can be used for nocturnal asthma
but the main benefit of LABA is their longer duration of action
What is isoprenaline and why is it not frequently used?
It is a non-selective beta agonist (works on both B1 and B2 adrenoceptors)
It will stimulate cardiac muscle as well as causing bronchodilatation
Selective B2 agonists are preferred for bronchodilation
Name a non-selective B arencoceptor agonist
Isoprenaline
Why is the use of propranolol dangerous in patients requiring bronchodilation therapy?
Propranolol is a non-selective B adrenoceptor antagonist
It blocks both B1 and B2 adrenoceptors
Adrenaline is required to bind to B2 adrenoceptors in the airways to ensure a relatively relaxed state is maintained
Upon propranolol administration, this cannot occur and there is a risk of bronchospasm
What happens when phospholipase A2 acts on activated mast cells?
Intracellular release of arachidonic acid occurs
After arachidonic acid is released intracellularly in mast cells, what happens when the mast cells are stimulated by 5-lipooxygenase (FLAP)
Arachidonic acid is metabolised to leukotriene A4 (LTA4) and then subsequently into LTB4 and LTC4which are both secreted into the extracellular spaceby transport proteins
LTB4 has what effects in the airways?
Causes infiltration of other inflammatory cells causing the production and release of other leukotrienes including CysLT1 (cysteinyl leukotriene)
LTB4 will also act as a chemokine attracting this leukotriene into the airway cells
What happens in the airways to LTC4?
It is metabolised to LTD4 and LTE4
(LTD4 can also metabolise to LTE4)
Whick leukotrienes will act on the CysLT1 receptor?
- LTD4
- LTE4
- CysLT1
Activation of the CysLT1 receptor will lead to what?
Contraction of bronchial smooth muscle. , increased vascular permeability, and mucus secretion.
(and later, inflammation)
In the USA, which drug is used to block stimulation is mast cells by 5-lipooxygenase?
Zileuton
What are two of the main CysLT1 antagonists?
- Montelukast
- Zafirlukast
Why are CysLT1 receptor antagonistsnot are not recommended for relief of severe acute asthma?
The main reason for this is that CysLT1 receptor antagonists have a slower onset of action compared to fast-acting bronchodilators such as salbutamol.
The bronchodilator activity of CysLT1 receptor antagonists is less than salbutamol, and they are not effective against all types of bronchoconstriction stimuli.
Therefore,
they cannot provide immediate relief of symptoms during a severe acute asthma attack.
They are not effective against all contractile stimuli
Salcutamol is effective against any provoking stimulus sue to acting in a physiological manner - cAMP pathway
How are CysLT1 receptor antagonists administered?
Orally
What are the two main methylxanthines?
- Theophylline
- Aminophylline
What are the two main actions methylxanthines take to counteract asthma symptoms?
- Bronchodilator action
- Anti-inflammatory action
Describe the bronchodilator action of methylxanthines
Normally cAMP is broken down to 5’AMP by phosphodiesterase enzymes
This prevents smooth muscle relaxation
Methylxanthines (at high doses) inhibit phosphodiesterase (3/4) and allow for smooth muscle relaxation
Levels of cAMP can activate protein kinase A which can phosphorylate and inhibit MLCK, or phosphorylate and stimulate myosin phosphotase - preventing contraction/allowing for relaxation
How is diaphragmatic contractility affected by the use of methylxanthines?
It is increased
This can reduce fatigue and improve ventilation
Describe the anti-inflammatory action of methylxanthines
At high doses, pro-inflammatory mediator release from mast cells is inhibited and mucociliary clearance is reduced
Methylxanthine can induce intra-cellular effects - they can activate histone deacetylase (HDAC) in the nucleus
HDAC removes acetyl groups (in histone proteins), increasing the +ve charge of histone tails and increasing bond strength between histones and DNA.
This means transcription of inflammatory genes occurs less frequently
Why does HDAC increase the strength of bonds between histones and the DNA backbone?
Normally acetylation occurs in histone proteins converting amines to amides which neutralises +ve charges
This reduces the amount of +ve charges from the histone proteins bonded to the -ve DNA backbone
This weakens the attraction and promotes the transcription of genes (inflammatory in the case of pharacology) as chromatin expands
HDAC prevents this acetylation occuring ensuring strong bonds remain between histones and DNA
Why are methylxanthines not high on the list for the treatment of asthma?
They have serious side effects and very narrow therapeutic window
- Seizures
- Hypotension, dysrhthmias
- GI tract issues - vomiting, discomfort
- Kidney problems